17 $g(b)-ARYL ESTER CARBOXYLATES OF 4-AZA-5$g(a)-ANDROSTANE-3-ONES
申请人:MERCK & CO. INC.
公开号:EP0664812A1
公开(公告)日:1995-08-02
EP0664812A4
申请人:——
公开号:EP0664812A4
公开(公告)日:1995-10-25
17-BETA-ARYL ESTER CARBOXYLATES OF 4-AZA-5-ALPHA-ANDROSTANE-3-ONES
申请人:Merck & Co., Inc.
公开号:EP0664812B1
公开(公告)日:2000-01-05
US5278159A
申请人:——
公开号:US5278159A
公开(公告)日:1994-01-11
[EN] 17 beta -ARYL ESTER CARBOXYLATES OF 4-AZA-5 alpha -ANDROSTANE-3-ONES<br/>[FR] 17 beta -ARYLE ESTER CARBOXYLATES DE 4-AZA-5 alpha -ANDROSTANE-3-ONES
申请人:MERCK & CO., INC.
公开号:WO1994007860A1
公开(公告)日:1994-04-14
(EN) Described are new 17$g(b)-aryl ester carboxylates of 4-aza-5$g(a)-androstan-3-ones and related compounds and the use of such compounds as 5$g(a)-reductase inhibitors for treatment of benign prostatic hyperplasia and other hyperandrogenetic related disorders.(FR) L'invention concerne de nouveaux 17$g(b)-aryle ester carboxylates de 4-aza-5$g(a)-androstane-3-ones et des composés apparentés ainsi que l'utilisation de tels composés en tant qu'inhibiteurs de 5$g(a)réductase pour le traitement de l'hyperplasie prostatique bénigne et autres troubles hyperandrogénétiques apparentés.